文献速递骨质疏松与代谢性骨病

类风湿关节炎与后续骨折风险:为更新FRAX进行的个体水平Meta分析

Rheumatoid arthritis and subsequent fracture risk: an individual person meta-analysis to update FRAX.
PubMed 文献 · Osteoporos Int · 2025-02-16

该国际个体水平Meta分析纳入29个前瞻性队列共1,909,896名20-116岁男女,评估类风湿关节炎(RA)与后续骨折风险的关联。主要分析中RA患病率1.3%,RA与任何临床骨折风险升高相关(HR 1.49,95%CI 1.35-1.65),髋部骨折风险更高(HR 2.23,95%CI 1.85-2.69),且 largely 独立于骨密度、性别和糖皮质激素暴露。结论认为RA应保留为FRAX的未来风险因素并更新风险函数。

要点

  • RA与任何临床骨折风险升高相关,HR 1.49(95%CI 1.35-1.65)。
  • RA与髋部骨折风险升高更明显,HR 2.23(95%CI 1.85-2.69)。
  • 髋部骨折风险与年龄存在显著交互,年轻年龄组HR更高。

核心结论

  • RA诊断 confer 骨折风险升高,且 largely 独立于骨密度、性别和糖皮质激素。
  • RA应保留为未来FRAX迭代中的风险因素,并更新风险函数以改善骨折风险预测。

研究设计与样本

  • 国际个体水平Meta分析,纳入29个前瞻性队列共1,909,896名20-116岁男女(主要分析),另补充17个RA患病率大于3%的队列。
  • 每个队列按性别使用Poisson回归模型扩展分析RA与骨折风险的关联,随后对加权beta系数进行随机效应Meta分析。

主要发现

  • 主要分析中RA患病率为1.3%,随访15,683,133人年期间发生139,002例骨折,其中27,518例为髋部骨折。
  • RA与任何临床骨折风险升高相关(HR 1.49,95%CI 1.35-1.65)。
  • RA与骨质疏松性骨折和主要骨质疏松性骨折(MOF)的HR magnitude 相似,但髋部骨折更高(HR 2.23,95%CI 1.85-2.69)。
  • 髋部骨折风险与年龄存在显著交互,年轻年龄组HR更高;HR在男女间无差异,且独立于糖皮质激素暴露和股骨颈骨密度。
  • 补充分析队列中观察到较低HR,尤其RA表观患病率高的队列,可能因RA与骨关节炎混淆。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 补充分析队列中观察到较低HR,尤其RA表观患病率高的队列,可能因RA与骨关节炎混淆。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: The relationship between rheumatoid arthritis (RA) and fracture risk was estimated in an international meta-analysis of individual-level data from 29 prospective cohorts. RA was associated with an increased fracture risk in men and women, and these data will be used to update FRAX®. INTRODUCTION: RA is a well-documented risk factor for subsequent fracture that is incorporated into the FRAX algorithm. The aim of this study was to evaluate, in an international meta-analysis, the association between rheumatoid arthritis and subsequent fracture risk and its relation to sex, age, duration of follow-up, and bone mineral density (BMD) with a view to updating FRAX. METHODS: The resource comprised 1,909,896 men and women, aged 20-116 years, from 29 prospective cohorts in which the prevalence of RA was 3% or less (primary analysis) and an additional 17 cohorts with a prevalence greater than 3% (supplementary analysis). The association between RA and fracture risk (any clinical fracture, osteoporotic fracture, major osteoporotic fracture (MOF), and hip fracture) was examined using an extension of the Poisson regression model in each cohort and each sex, followed by random-effects meta-analyses of the weighted beta coefficients. RESULTS: In the primary analysis, RA was reported in 1.3% of individuals. During 15,683,133 person-years of follow-up, 139,002 fractures occurred, of which 27,518 were hip fractures. RA was associated with an increased risk of any clinical fracture (hazard ratio [HR] 1.49, 95% confidence interval [CI] 1.35-1.65). The HRs were of similar magnitude for osteoporotic fracture and MOF but higher for hip fracture (HR = 2.23; 95% CI 1.85-2.69). For hip fracture, there was a significant interaction with age with higher HRs at younger ages. HRs did not differ between men and women and were independent of exposure to glucocorticoids and femoral neck BMD. Lower HRs were observed in the supplementary analysis cohorts, particularly in those with a high apparent prevalence of RA, possibly from conflation of RA with osteoarthritis. CONCLUSIONS: A diagnosis of RA confers an increased risk of fracture that is largely independent of BMD, sex, and corticosteroids. RA should be retained as a risk factor in future iterations of FRAX with updated risk functions to improve fracture risk prediction.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Kanis JA, Johansson H, McCloskey EV, et al. Rheumatoid arthritis and subsequent fracture risk: an individual person meta-analysis to update FRAX. Osteoporos Int. 2025. PMID: 39955689. doi:10.1007/s00198-025-07397-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。